1 / 4

Pet Cancer Therapeutics Market forecast to see more than 10% CAGR from 2017 to 2024

Get more details @ http://bit.ly/2vzOqU5 <br>The Pet cancer therapeutics sector is a relatively new compared to other pet healthcare sectors. Increasing trend of pet adoption such as dogs and cats owing to improved economic status of people will drive pet cancer therapeutics market size.

jueekate
Download Presentation

Pet Cancer Therapeutics Market forecast to see more than 10% CAGR from 2017 to 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pet Cancer Therapeutics Market forecast to grow at 10% CAGR from 2017 to 2024: Global Market Insights Inc. The medical industry report “Pet Cancer Therapeutics Market Size By Medicine Type (Chemotherapy Drugs and Vaccines), By Species (Dogs and Cats), By Cancer Type (Lymphoma, Mast Cell Cancer Tumors, Melanoma, Mammary and Squamous Cell Cancer), Regional Outlook (U.S., Canada, Germany, UK, Spain, Italy, France, China, Japan, India, Australia, Brazil, Mexico), Technology Development, Competitive Landscape & Forecast, 2017 – 2024”, by Global Market Insights, Inc. says Pet Cancer Therapeutics Market size to exceed USD 300 million by 2024. Growing pet adoption rate coupled with increasing disposable income of pet owners will drive pet cancer therapeutics market growth. Strong and robust drug pipeline for treatment of pet cancer will stimulate business growth over the forecast years. High cost of pet cancer drugs along with rising instances of adverse drug events should hamper industry growth over the forecast years. Lack of awareness regarding pet diseases among the pet owners will impede industry expansion. Chemotherapy has been the mainstream medication for pet cancers till recent times. However, immunological vaccines entered the market and are gaining significant market share. With number of chemotherapy drugs in pipeline, the industry should witness considerable growth over the coming years. Dogs are more prone to develop cancer than cats and the healthy pipeline will drive segment growth over the forecast years. However, introduction of specialized cat cancer medicines will stimulate the cat cancer therapeutics market growth. Pet healthcare companies are focusing on development of drugs for mast cell cancer and melanoma among other cancer types. This trend will witness change as medicines to treat lymphoma and mammary cell cancer are in the pipeline. Innovative medicines for treatment of multiple cancer tumors is anticipated to accelerate business growth. 1 | P a g e

  2. U.S. Pet cancer therapeutics market, by medicine type, 2013 - 2024 (USD Million) Browse key industry insights spread across 95 pages with 80 market data tables & 9 figures & charts from this 2017 report Pet Cancer Therapeutics Market in detail along with the table of contents at: https://www.gminsights.com/industry-analysis/pet-cancer-therapeutics-market U.S. pet cancer therapeutics market holds the largest revenue share in 2016. Presence of large number of pet drug manufacturing companies, quick adoption of innovative pet care medicines and increasing disposable income of pet owners will boost industry growth. Australia pet cancer therapeutics market held highest regional revenue share in 2016 owing to growing pet-keeping trend, availability of innovative pet care medicines and increasing disposable income of pet owners. Some of the leading industry players include Zoetis, Merial, Aratana Therapeutics, AB Science, Vetivax, Oasmia Pharmaceutical, VetDC, Regeneus, CanFel Therapeutics, Karyopharms Verdinexor. The most commonly adopted business strategies by industry participants includes new product launches, regional expansion and mergers and acquisition. Segmentation of Pet Cancer Therapeutics Market: Pet cancer therapeutics market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2013 to 2024, for the following segments: 2 | P a g e

  3. Pet Cancer Therapeutics Market By Medicine Type •Chemotherapy drugs •Vaccines Pet Cancer Therapeutics Market By Species •Dogs •Cats Pet Cancer Therapeutics Market By Cancer Type •Lymphoma •Mast cell cancer •Melanoma •Mammary and Squamous cell cancer The above information is provided for the following regions/countries: •North America oU.S. oCanada •Europe oUK oGermany oFrance oSpain oItaly •Asia Pacific oChina oIndia oJapan oAustralia •Latin America oBrazil oMexico About Global Market Insights: Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for 3 | P a g e

  4. key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology. Contact Us: Arun Hegde Corporate Sales, USA Global Market Insights, Inc. Phone: 1-302-846-7766 Toll Free: 1-888-689-0688 Email: sales@gminsights.com Website: https://www.gminsights.com/ 4 | P a g e

More Related